CLEVELAND BIOLABS INC - COM NEW (CBLI) Institutional Ownership

CUSIP: 185860202

13F Institutional Holders and Ownership History from Q1 2015 to Q4 2021

Type / Class
Equity / COM NEW
Symbol
CBLI
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 185860202?
CUSIP 185860202 identifies CBLI - CLEVELAND BIOLABS INC - COM NEW in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of CLEVELAND BIOLABS INC - COM NEW (CBLI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2021 Q4 0 $0 -$2,000 0
2021 Q3 0 $0 -$4,300,641 0
2021 Q2 786,994 $4,302,641 -$1,529,656 $5.47 16
2021 Q1 1,067,304 $5,601,575 +$2,988,918 $5.25 16
2020 Q4 622,517 $2,147,035 +$998,830 $3.45 15
2020 Q3 344,665 $678,788 -$138,025 $1.97 13
2020 Q2 415,090 $1,066,028 +$44,170 $2.57 10
2020 Q1 407,050 $676,166 +$30,531 $1.66 10
2019 Q4 399,490 $240,000 -$42,705 $0.60 7
2019 Q3 449,198 $454,000 +$66,282 $1.02 10
2019 Q2 382,009 $554,000 -$75,160 $1.44 6
2019 Q1 434,027 $725,000 -$12,263 $1.66 5
2018 Q4 450,072 $454,000 -$63,172 $1.01 7
2018 Q3 513,098 $1,031,000 -$7,078 $2.01 6
2018 Q2 513,097 $1,262,000 +$63,176 $2.46 7
2018 Q1 487,726 $1,485,000 +$131,398 $3.02 7
2017 Q4 440,609 $1,767,000 +$23,208 $4.01 6
2017 Q3 438,173 $1,509,000 +$37,682 $3.44 12
2017 Q2 477,327 $1,405,000 +$956,142 $2.93 12
2017 Q1 191,241 $298,000 -$20,784 $1.57 8
2016 Q4 210,334 $305,000 +$17,150 $1.42 12
2016 Q3 191,792 $340,000 +$72,196 $1.74 12
2016 Q2 110,220 $311,000 -$38,626 $2.84 6
2016 Q1 126,347 $320,000 -$31,415 $2.53 9
2015 Q4 176,207 $644,000 +$23,995 $3.64 13
2015 Q3 166,837 $713,000 -$90,001 $4.31 9
2015 Q2 148,533 $644,161 -$136,956 $4.34 10
2015 Q1 203,379 $720,132 +$720,132 $3.58 12